28332. Adulteration and misbranding of acetanilide and salol tablets, Blaud's 
Tablets, and phenolpbthaleln tablets. IT. S. v. George A. Colvin and 
Humphrey D. Brock (Brunswick Tablet Co.). Pleas of nolo contendere. 
Fines of $50 and costs. (F. & D. No. 39782. Sample Nos. 6550-C, 14841-C, 
14844-C, 33426-C, 33430-C.)
The acetanilide and salol tablets contained less acetanilide and salol than 
declared; the Blaud's Tablets contained less ferrous carbonate than required 
by the pharmacopoeia and less iron sulphate exsiccated than declared; the 
phenolphthalein tablets contained four-fifths the labeled amount of phenol- 
phthalein.
On October 22, 1937, the United States attorney for the Northern District of 
Illinois, acting upon a report by the Secretary of Agriculture, filed in the 
district court an information against George A. Colvin and Humphrey D. Brocker 
trading as the Brunswick Tablet Co., at Chicago, Ill., alleging shipment in viola- 
tion of the Food and Drugs Act by the said defendants on or about February 26r 
March 13 and 20, 1937, from the State of Illinois into the States of Michigan 
and Wisconsin, of quantities of drug tablets which were adulterated and mis- 
branded. The articles were labeled in part: "Manufactured by Brunswick 
Tablet Company, Manufacturing Chemists, Chicago, Illinois."
The acetanilide and salol tablets were alleged to be adulterated in that their 
strength and purity fell below the professed standard and quality under which 
they were sold, in that each of the tablets was represented to contain 2% grains 
of acetanilide and 2y2 grains of salol; whereas each of said tablets contained 
less than 2% grains, namely, not more than 2.12 grains of acetanilide and 2.25 
grains of salol. The said articles were alleged to be misbranded in that the 
statement borne on the bottle label, "Tablets * * * Acetanilide 2% gr.; Salol 
2% gr.," was false and misleading.
The Blaud's Tablets were alleged to be adulterated in that they were sold 
under a name recognized in the United States Pharmacopoeia, and differed 
from the standard of strength, quality, and purity, as determined by the test 
laid down in the pharmacopoeia in that each tablet contained less than 0.06 
gram of ferrous carbonate—samples of the two shipments having been found 
to contain not more than 0.046 and 0.043 gram respectively; whereas the phar- 
macopoeia provides that Blaud's pills, i. c, Blaud's tablets, each shall contain 
not less than 0.06 gram of ferrous carbonate, and the standard of strength, 
quality, and purity of the article was not declared on the container thereof. 
The article was alleged to be adulterated further in that its strength and purity 
fell below the professed standard and quality under which it was sold, in that 
each of said tablets was represented to contain 2% grains of iron sulphate 
exsiccated; whereas each of said tablets contained less than 2y2 grains,—sam- 
ples from the two shipments having been found to contain not more than 1.08 
grains and 1.01 grains, respectively, of iron sulphate exsiccated. The said 
article was alleged to be misbranded in that the statement on the bottle label, 
"Tablets   *    *    *   Iron Sulp. Ex. 2% grains," was false and misleading.
The phenolphthalein tablets were alleged to be adulterated in that they were 
sold under a name recognized in the National Formulary, and differed from 
the standard of strength, quality, and purity as determined by the test laid 
down in the formulary in that each of said tablets was represented by the 
label to contain 1 grain of phenolphthalein, whereas they contained less than 
1 grain, namely, not more than approximately four-fifths grain of phenolphtha- 
lein—samples of the two shipments having been found to contain not more than
81 percent and 82 percent, respectively, of the labeled amount; whereas the 
formulary provides that tablets of phenolphthalein shall contain not less than 
92.5 percent of the labeled amount of phenolphthalein, and the standard of 
strength, quality, and purity of the article was not declared on the container 
thereof. The said article was alleged to be misbranded in that the statement 
borne on the bottle label, "Tablets Phenolphthalein, 1 Grain," was false and 
misleading.
On December 13, 1937, pleas of nolo contendere having been entered by the 
defendants, they were each sentenced to pay a fine of $25, totaling $50 and 
costs.
HARRY L. BROWN, Acting Secretary of Agriculture.